Skip to content

Organogenesis Holdings Inc. ORGO Proceeds from issuance of preferred stock

Proceeds from issuance of preferred stock at other companies

Evolution Metals & Technologies Corp.
 logo
Evolution Metals & Technologies Corp. EMAT
$5.55M
Maze Therapeutics, Inc. Common Stock logo
Maze Therapeutics, Inc. Common StockMAZE
$17.7M
LBR
LB Pharmaceuticals Inc Common StockLBRX
$0-100%
Evommune
 logo
Evommune EVMN
$2M
Peapack-Gladstone Financial logo
Peapack-Gladstone FinancialPGC
$30M
Lightpath Technologies logo
Lightpath TechnologiesLPTH
$4.67M

Other financials

Income statement

See full
Revenue$37.2M-57.1%
Gross profit$63.0M-22.5%
Operating income-$68.9M-158%
Net income-$53.2M-182%
EPS (diluted)-$0.44-159%

Balance sheet

See full
Cash & equivalents$91.4M-16.9%
Total debt$39.4M+24.8%
Total equity$244.6M+0.7%
Total assets$520.0M+11.3%

Cash flow

See full
Operating cash flow$21.1M+206%
CapEx$3.1M-13.2%
Free cash flow$18.0M+176%

Valuation

See full
Market cap$312.68M-23.7%
Enterprise value$260.72M-21.3%
P/E115×
P/S0.6×-0.3×

Profitability

See full
Gross margin75.9%+0.8pp
Operating margin0.5%
Net margin0.5%+0.3pp
FCF margin6.9%

Returns & leverage

See full
Return on equity1.1%+0.6pp
Debt / equity0.2×0.0×
Current ratio3.5×-0.6×

Where this comes from

Reported directly by Organogenesis Holdings Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock.

The official record: Organogenesis Holdings Inc.’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organogenesis Holdings Inc.'s proceeds from issuance of preferred stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organogenesis Holdings Inc.'s proceeds from issuance of preferred stock?
Organogenesis Holdings Inc. (ORGO) reported proceeds from issuance of preferred stock of $30.17M in Q4 2024.
What does proceeds from issuance of preferred stock mean?
Cash received from issuing preferred stock — hybrid equity that provides fixed dividends without common stock dilution.